FDA Investigator Allen F Hall

Allen F Hall has conducted inspections on 250 sites in 23 countries as of 09 Nov 2015. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
250
Last Inspection Date:
09 Nov 2015
Investigator Role:
FDA Investigator
Redica ID:
100002811
Countries of Inspections:
United States of America, United Kingdom of Great Britain and Northern Ireland, Sweden, Mexico, Canada, India, Honduras, Serbia, Russian Federation, Italy, France, Brazil, Japan, Bulgaria, Netherlands, Germany, Romania, Belgium, South Africa, Switzerland, Finland, Spain
FDA Investigators that have inspected at least one site in common with Allen F Hall:
Ademola O Daramola, Alan P Kurtzberg, Alanna L Mussawwir Bias, Alexandra B Pitkin, Alia Legaux, Amanda E Lewin, PhD, Ana M Pietsch, Anderson, Andrace L Deyampert, Andrea A Branche, Angela Shepas, Anna Lazar, Anthony E Keller, RPh, Anthony J Ladner, Arindam Dasgupta, PhD, Armando Chavez, MS, Barbara A Rusin, Barbara Janine Breithaupt, Barbara M Frazier, Bonita S Chester, Brian Ravitch, Brooke K Higgins, Brunilda Torres, Carl J Montgomery, Carla J Lundi, Carol S Sanchez, CDR Ileana Barreto Pettit, CDR Rochelle B Young, RPh, MSA, Charles L Larson, Charles R Cote, RIC, Charma Konnor, Cheron M Portee, Cheryl D Mccall, Cheryl Love Harris, Christian D Lynch (CDL), Christina D Mello, Christine M Whitby, CSO, Christine W Twohy, Comyar Shoghi, Courtney N Long, Craig A Garmendia, Ct Viswanathan, PhD, Dana M Klimavicz, Daniel L Aisen, Dannie E Rowland, David G Whitman, David Kalins, David R Heiar, Dawn C Olenjack, Denise L Burosh, Diana L Ayala, Diane Cvan Leeuwen, Donna Ltartaglino Besone, Douglas A Campbell, Douglas C Kovacs, Dr. Gopa Biswas, PhD, Dr. Guang Gao, PhD, Dr. Sriram Subramaniam, PhD, Dr. Zhihao Qiu (Peter), PhD, Durell L Giles, Edward Deberry, Eric E Joneson, Eric M Mueller, PharmD, Eric W Anderson, Felix Maldonado, Finn A Slizza, Gajendiran Mahadevan, PhD, Gene D Arcy, Geoffrey K Kilili, Gerald N Mcgirl, DDS, Gulshan R Anand, Gwyn G Dickinson, Habacuc V Barrera, Herminio C Francisco, Himanshu Gupta, PhD, Hyojong Kwon, PhD, Iris C Macinnes, Jacqueline A O'shaughnessy, PhD, James A Lane, James R Fleckenstein, James R Montero, Janet K White, Janete F Guardia, Jeanne D Shaffer, Jeanne M Morris, Jennifer A Longie Vollom, Jennifer C Adams, Jennifer M Gogley, Jenny L Chisem, Jenny L Mccardell, Jocelyn E Massey, Jocelyn E Sparks, Joel D Martinez, Joey V Quitania, Jogy George, John A Iwen, John A Kadavil, PhD, John S Hartford, Jose A Lopez, Joshua P Wireman, Juanj N Wu, Julian C Hanson, Ka L Wong, Kaitlyn T Dang, Kara A Scheibner, PhD, Karen M Kondas, Katherine E Jacobitz, Kathryn A Krentz, Kellia N Hicks, Kelvin Cheung, Kevin A Gonzalez, Kevin N Tran, Kevin T Gerrity, Kham Phommachanh, Kip J Hanks, Kirsten S Tharp, Kirtida Patel, Kristin M Abaonza, Lakecha N Lewis, Lan T Tran, Larry K Austin, Laureen F Kononen, Laverne Kimble, Leonard H Lavi, Li Hongpaul Yeh, PhD, Liatte Kreuger, PharmD, Linda Galindo, Linda R Kuchenthal, Linda Thai, Lisa P Oakes, Lori A Gioia, Lynette M Terry, Marc A Jackson, Jr, Marc R Dickens, Margaret M Annes, Marilyn S Babu, Mariza M Jafary, Mark C Saale, Martin K Yau, PhD, Mary Ewilkerson Brinsko, Matthew C Watson, Matthew J Gretkierewicz, Mei Chen Mu, Mendoza O Wallace, Michael F Skelly, PhD, Michael S Araneta, Michelle D Haamid, Michelle J Hines, Michelle M Noe Varga, Minh D Phan, Mohsen Rajabi Abhari, FDA, Muralidhara B Gavini, PhD, Myra K Casey, Nancy A Bellamy, Natalie J Ayoub, Natalie J Reese, Nathan R Moon, Ni Aye Khin, MD, Nicholas Fragedakis, Nicola M Fenty Stewart, Nilufer M Tampal, PhD, Omotunde O Osunsanmi, Paula A Trost, Paula J Bretz, Phal K Chhun, Prabhu P Raju, Raymond W Brullo, Rebecca T Davis, Robert C Steyert, Robert S Sweeton, Rochelle A Rolnik, Rodney G Raiford, Rodney T Allnutt, Roger F Zabinski, Ronald L Koller, Ronda Rloyd Jones, Ruben C Ayala, PharmD, Sam H Haidar, PhD, Samson O Oluseye, Sandra L Shire, DMD, MPA, Sara Jdent Acosta, Sarah E Mcmullen, Scott B Laufenberg, Scott K Zika, Sean P Desbrow, Selene T Torres, Shaquenta Y Perkins, Sherri N Rohlf, MD, Sonia R Peterson, Sonya L Karsik, RAC, Sparky L Bartee, Sripal R Mada, PhD, Stanley B Eugene, BS, BME, Sunitha K Rajaram, PhD, Susan D Yuscius, Susan F Laska, MS, Susanne M Richardson, MS RAC, Suzie L Kent, Tawny L Colling, Teena H Aiken, Terrance L Thomas, Theressa B Smith, Thomas R Beilke, Timothy P Lafave, Timothy T Kapsala, Tonia L Sawyer, Trudy R Papson, Uros V Djekic, PhD, Valerie L Whipp, Vickie J Kanion, Vickie L Anderson, Vien Q Le, Virgilio F Pacio, CSO, Walden H Lee, Wayne T Smith, William D Boden, William S Vitale, Wr Bowman, Xiaohan Cai, PhD, Xikui Chen (nmi), PhD, Young M Choi, PhD, Yvette E Guillermo, Yvonne T Lacour, Zerita White

Allen F Hall's Documents

Publish Date Document Type Title
July, 2003 FDA 483 Response Allied Clinical Research - Form 483R, 2003-07-22
March, 2002 EIR Mollen, Martin D., MD - EIR, 2002-03-14
April, 2002 EIR IRB Inc - EIR, 2002-04-25
October, 2000 FDA 483 Novopharm Limited - Form 483, 2000-10-19
September, 2015 EIR Ardea Biosciences, Inc. - EIR, 2015-09-25
June, 2004 EIR ACCUTEST RESEARCH LABORATORIES ( I ) - EIR, 2004-06-11
August, 2015 FDA 483 Teirstein, Paul S. MD - Form 483, 2015-08-17
February, 2001 FDA 483 Mentor Worldwide LLC - Form 483, 2001-12-06
April, 2012 FDA 483 Response W. L. Gore & Associates, Inc. - Form 483R, 2012-04-24
March, 2012 FDA 483 Michael Gordon MD - Form 483, 2012-03-16
October, 2010 FDA 483 Biomedical Research Inst. of America - Form 483, 2010-10-25
November, 2003 FDA 483 Pratha, Vijaya S MD Clinical Applications Labs Inc - Form 483, 2003-11-04
July, 2003 EIR Allied Clinical Research - EIR, 2003-07-22
January, 2015 EIR Bernard A Michlin, MD - EIR, 2015-01-23
October, 2000 FDA 483 Biovail Contract Research - Form 483, 2000-10-27
October, 2010 EIR Biomedical Research Inst. of America - EIR, 2010-10-25
November, 2002 EIR Skaggs, David, MD - EIR, 2002-11-21
September, 2015 FDA 483 Ardea Biosciences, Inc. - Form 483, 2015-09-25
January, 2014 EIR Purvi Mehra, MD - EIR, 2014-01-29
February, 2003 EIR Boston Scientific Corporation - EIR, 2003-02-28
March, 2002 FDA 483 Mollen, Martin D., MD - Form 483, 2002-03-14
January, 2000 EIR Mission Bay Mem Hospital Irb - EIR, 2000-01-28
April, 2004 FDA 483 Intertek USA, Inc. - Form 483, 2004-04-02
March, 2010 EIR Celerion Switzerland Ag - EIR, 2010-03-13
April, 2004 EIR Intertek USA, Inc. - EIR, 2004-04-02
November, 2003 EIR Pratha, Vijaya S MD Clinical Applications Labs Inc - EIR, 2003-11-04
November, 2001 EIR Yu, Alice, L. - EIR, 2001-11-16
March, 2002 FDA 483 Roh, Daeyoung - Form 483, 2002-03-01
April, 2012 FDA 483 W. L. Gore & Associates, Inc. - Form 483, 2012-04-13
March, 2010 EIR MSD - EIR, 2010-03-05
January, 2000 FDA 483 Thomas S. Tooma, M.D. - Form 483, 2000-01-13
December, 2009 EIR Molecular Diagnostics Services, Inc. - EIR, 2009-12-07
June, 2001 EIR Irvine Regional Hospital and Medical Center - EIR, 2001-06-14
June, 2001 FDA 483 Irvine Regional Hospital and Medical Center - Form 483, 2001-06-14
November, 2014 FDA 483 Maria Opris - Form 483, 2014-11-21
January, 2007 FDA 483 Parexel Bionanalytical Services Division - Form 483, 2007-01-19
January, 2007 EIR Parexel Bionanalytical Services Division - EIR, 2007-04-04
December, 2003 EIR Coast IRB LLC - EIR, 2003-12-17
December, 2003 FDA 483 Coast IRB LLC - Form 483, 2003-12-17
October, 2000 EIR Biovail Contract Research - EIR, 2000-10-27
July, 2003 FDA 483 Response MDS Pharma Services - Form 483R, 2003-07-17
September, 2012 EIR Intertek USA, Inc. - EIR, 2012-09-28
January, 2002 EIR Molecular Diagnostics Services, Inc. - EIR, 2002-01-31
January, 2004 EIR Surgilight, Inc. - EIR, 2004-01-05
February, 2003 FDA 483 Boston Scientific Corporation - Form 483, 2003-02-28
July, 2003 FDA 483 MDS Pharma Services - Form 483, 2003-07-17
November, 2001 FDA 483 Yu, Alice, L. - Form 483, 2001-11-16
May, 2011 FDA 483 Parexel Bionanalytical Services Division - Form 483, 2011-05-17
March, 2002 FDA 483 Response Roh, Daeyoung - Form 483R, 2002-03-14
October, 2003 FDA 483 Cheung, Deanna G MD - Form 483, 2003-10-10
May, 2011 EIR Parexel Bionanalytical Services Division - EIR, 2011-05-17
November, 2014 FDA 483 Sotir Marchev - Form 483, 2014-11-14
January, 2004 FDA 483 Surgilight, Inc. - Form 483, 2004-01-05
April, 2002 FDA 483 IRB Inc - Form 483, 2002-04-25
January, 2000 FDA 483 Mission Bay Mem Hospital Irb - Form 483, 2000-01-28
November, 2002 FDA 483 Skaggs, David, MD - Form 483, 2002-11-07
January, 2015 FDA 483 Bernard A Michlin, MD - Form 483, 2015-01-23
July, 2003 FDA 483 Piyush Patel, M.D. FRCP - Form 483, 2003-07-22
March, 2002 EIR Roh, Daeyoung - EIR, 2002-03-21
January, 2007 FDA 483 Response Parexel Bionanalytical Services Division - Form 483R, 2007-01-19
June, 2010 FDA 483 Michael Dean Berger MD - Form 483, 2010-06-10
October, 2003 EIR Cheung, Deanna G MD - EIR, 2003-10-10
August, 2011 FDA 483 Biomedical Research Inst. of America - Form 483, 2011-08-19
April, 2012 EIR W. L. Gore & Associates, Inc. - EIR, 2012-04-13
July, 2003 EIR MDS Pharma Services - EIR, 2003-09-24
October, 2000 FDA 483 Response Biovail Contract Research - Form 483R, 2000-11-09

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more